Questions to consider when talking to your healthcare provider about treatment.
Get information on GOMEKLI, including its potential benefits, possible side effects, dosing, and more.
See how adults may experience GOMEKLI, the first and only approved treatment for people 18+ with NF1-PN.
NF1-PN=neurofibromatosis type 1 with plexiform neurofibromas.
The following resources were designed to prepare you for your journey with GOMEKLI.
Find helpful information on what to expect from GOMEKLI and the support offered through SpringWorks CareConnections.
Keep notes on how you’re feeling while taking GOMEKLI to let your care team know how you’re doing.
A detailed look at free, personalized support from SpringWorks CareConnections.
The resources below can support you throughout GOMEKLI treatment.
Hear some tips on how to stay engaged in your care and on top of your GOMEKLI treatment over time.
A full library of videos that can help you throughout treatment.
SpringWorks has partnered with Medisafe, the #1 medication management app, to give people taking GOMEKLI a free resource: the GOMEKLI Digital Companion.
Find support in the palm of your hand with:
A free resource to support you or your loved one throughout GOMEKLI treatment.
How to access the GOMEKLI Digital Companion
Yes, GOMEKLI is the first FDA-approved treatment for both adults and children 2 years of age and older with neurofibromatosis type 1 (NF1) who have symptomatic plexiform neurofibromas (PN) not amenable to complete resection.1
The efficacy and safety of GOMEKLI were evaluated in both adult and pediatric patients in the phase 2b, single-arm ReNeu study.1,2 See the ReNeu study design.
Follow the steps below to download Medisafe and access the GOMEKLI Digital Companion:
Tap “Get” or “Install” to download the FREE Medisafe app.
Tap “Get” or “Install” to download the FREE Medisafe app.
Open Medisafe, then tap “Get Started”.
Open Medisafe, then tap “Get Started”.
Complete the onboarding steps and access the GOMEKLI Digital Companion.
Complete the onboarding steps and access the GOMEKLI Digital Companion.
Finding a healthcare provider who is familiar with NF1 is the most important thing you can do for yourself or your loved one. Use this tool to locate an experienced healthcare provider near you.
Healthcare providers in this database may be recognized by the NF Network, or be members of the Children’s Tumor Foundation’s NF Clinic Network, as noted in their profiles.
These websites also feature tools that can help you locate healthcare providers throughout the US who are familiar with NF1.
SpringWorks Therapeutics is providing these independent resources to help patients find an NF1 treater by region, but SpringWorks Therapeutics had no role in their development. Their inclusion on this website does not represent an endorsement or a recommendation from SpringWorks Therapeutics for any center or physician.
The GOMEKLI Patient Mentor Program is a way to connect virtually with someone living with, or caring for someone living with, NF1-PN who may be able to relate to what you are experiencing.
This program is designed for you to have a one-on-one phone call with a GOMEKLI Guide, during which they will share their personal NF1-PN story and talk about their experience on GOMEKLI. When you register for the program, you will have an opportunity to choose specific topics to discuss on the call, including their experience with things like:
To be eligible to participate in the program, you must be at least 18 years of age, reside in the United States, and have, or care for someone who has, a valid prescription for GOMEKLI from a healthcare provider licensed in the United States for an FDA-approved indication.
If you would like to connect with someone in the GOMEKLI Patient Mentor Program, register below to get started.
GOMEKLI (mirdametinib) is a prescription medicine used to treat adults and children 2 years of age and older with neurofibromatosis type 1 (NF1) who have plexiform neurofibromas that cause symptoms and cannot be completely removed by surgery.
It is not known if GOMEKLI is safe and effective in children under 2 years of age.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
See the “Instructions for Use” that come with your medicine for instructions on how to prepare and take GOMEKLI tablets for oral suspension.
GOMEKLI may cause fertility problems in females, which may affect your ability to have children. Talk to your healthcare provider if you have concerns about fertility.
It is not known if GOMEKLI is safe and effective in children under 2 years of age.
SpringWorks Therapeutics is providing this tool to help patients find healthcare providers by location who have experience treating neurofibromatosis type 1.
The doctor finder is an independent third-party search widget. The links to third-party websites are provided solely for your convenience; SpringWorks Therapeutics does not control the content contained on any third-party website. Your activities at those websites will be governed by the policies and practices of those third parties.
No fees have been received by SpringWorks Therapeutics or paid to any healthcare professional for inclusion in this specialist locator directory. All healthcare provider information is self-reported or was obtained from a publicly available third-party source. This information is subject to change. Please verify the information provided before making an appointment with any healthcare professional listed here.
Inclusion in this database does not represent an endorsement or recommendation from SpringWorks Therapeutics, nor do any of these physicians necessarily prescribe or endorse any SpringWorks Therapeutics products. SpringWorks Therapeutics may or may not have a relationship with any of these physicians. The selection of a physician is your responsibility and is an important decision that should be carefully considered.
If you are a healthcare professional and would like to be removed from the database, please email feedback@medifind.com.
If you are a healthcare professional with experience in NF1 and would like to be included in the database, please contact feedback@medifind.com.
You are now leaving GOMEKLI.com, a website provided by SpringWorks Therapeutics. This link will take you to a different site to which this Privacy Policy and Terms of Use do not apply.
Tap "Continue" if you are a US Healthcare Professional.